OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  

OncoDaily
Jun 27, 2024, 02:23 | Blog
Sarah Adly: Our Article on 'Optimizing Outcomes in Advanced Renal Cell Carcinoma'
Sarah Adly, NCODA Fellow in Oncology, made the following post on LinkedIn:      .…
Jun 27, 2024, 02:05 | Blog
Yan Leyfman: Grateful for an unparalleled experience at ASCO Breakthrough
Yan Leyfman, Internal Medicine and Clinical Researcher at Icahn School of Medicine at Mount Sinai,…
Jun 27, 2024, 01:42 | Blog
Phuong Ly-Gallagher: 17 years of colorectal cancer survivorship
Phuong Ly-Gallagher, Research Advocate Training and Support (RATS) Manager at Fight Colorectal Cancer, shared on…
Jun 27, 2024, 00:50 | Blog
Joshua Omale: Explaining second-hand smoking to the students
Joshua Omale shared on LinkedIn:  . “Empowering the Next Generation: A Continued Journey with the…
Jun 26, 2024, 16:33 | Blog
Courtney McGowan discusses healthy eating for patients with cancer - Yale Cancer Center
Yale Cancer Center shared on X: "Tonight at 7:30pm on Yale Cancer Answers, registered oncology dietitian…
Jun 26, 2024, 16:21 | Insight
Lumír Kunovský: Pancreas2000 project
Recently Lumír Kunovský, Associate Professor at the University Hospital Brno, shared a post on X…
Jun 26, 2024, 16:12 | Blog
How rare disease impacted John Crowley's children and the importance of access to care - ACSCAN Massachusetts
ACSCAN Massachusetts shared a post on X: "Our Keynote today, John Crowley, President and CEO…
Jun 26, 2024, 16:05 | Blog
$300,000 for innovative research focused on Tumor Treating Fields - AACR
American Association for Cancer Research (AACR) shared a post on X:   . "The AACR-Novocure Career…
Jun 26, 2024, 15:48 | Blog
Enes Erul: Case presentation at the ESOncology masterclass
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University and Research Fellow at Dana-Farber Cancer Institute,…
Jun 26, 2024, 15:32 | Blog
Sleep Apnea is hepled by GLP-1 drugs
Toni Choueiri shared on X: "Just in ⁦NEJM⁩: Sleep Apnea is also helped by the GLP-1…
Jun 26, 2024, 15:22 | Insight
Results from the NIAGARA Phase III trial
AztraZeneca released the results of the NIAGARA phase III trial, where INFINZI (durvalumab) showed EFS…
Jun 26, 2024, 15:14 | Blog
Updated 2023 impact factor list for hematology/oncology journals
Eddie Cliff, Postdoctoral Research Fellow at Harvard Medical School, shared a post on X:  .…
Jun 26, 2024, 15:13 | Blog
Toni Choueiri: Our new IMDC paper in ESMO Open led by Kosuke Takemura
Toni Choueiri shared a post by Kosuke Takemura, Staff Urologist at Ganken Hospital, on X: "Our new…
Jun 26, 2024, 15:03 | Blog
Summary of the top myeloma research presented at ASCO and EHA 2024 - IMF
International Myeloma Foundation shared a post on X:     . "Join International Myeloma Foundation (IMF) virtually…
Jun 26, 2024, 14:55 | Blog
Sarah P. Psutka: Grateful to be part of this incredible international community of UroOncs
Shilpa Gupta shared a post by Sarah P. Psutka, Associate Editor at European Urology, on X: "Thanks Morgan…
Jun 26, 2024, 14:53 | Blog
Patrick Forde: Consensus recommendations from IASLC for lung cancer
Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies at Sidney Kimmel Comprehensive Cancer Center,…
Jun 26, 2024, 14:43 | Blog
Jonathan Spicer: Incredible pace of development for patients with resectable NSCLC
Jonathan Spicer,  Medical Director of the McGill Thoracic Oncology Program, shared a post on X:…
Jun 26, 2024, 14:40 | Blog
Shahrin Ahmed: Providing solutions for one of the most challenging cancers
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X:    . “Multiple…
Jun 26, 2024, 14:33 | Blog
NOM after IO in early-stage MSI-H GI cancers
Deniz Can Guven, The Editorial Board Member in BMC Cancer, shared on X: "Out in Cancer…
Jun 26, 2024, 14:28 | Blog
Alexey Danilov on the treatment of R/R Follicular Lymphoma - The Video Journal of Hematology and Hematological Oncology
The Video Journal of Hematology and Hematological Oncology shared on X: "It was great to catch…
Jun 26, 2024, 14:26 | Blog
Tunji Alausa: Pleased to lead the Nigerian delegation to facilitate licensing for Nigerian Physicians in Diaspora
Tunji Alausa, State Minister for Health and Social Welfare of Nigeria, shared on LinkedIn:  .…
Jun 26, 2024, 14:17 | Blog
Analysis of post-hoc of CAIRO5
Arndt Vogel shared on X: "Prognostic value of total tumor volume in CRC liver metastases.…
Jun 26, 2024, 14:10 | Blog
Maria Babak: Rapid Progress in Metastatic Urothelial Carcinoma
Maria Babak shared a post by The Babak Lab on LinkedIn: “The FDA's approval of…
Jun 26, 2024, 13:57 | Blog
Haggai Elisha: Our mission to inspire and raise young ambassadors for the prevention of Non-Communicable Diseases presses on
Haggai Elisha, student of Biochemistry at the University of Jos, shared a post on LinkedIn: …
Jun 26, 2024, 13:51 | Insight
Tom Powles: Durvalumab with neoadjuvant chemo then cystectomy in MIBC
Tom Powles shared on X: "Positive results from the NIAGARA Phase III trial showed durvalumab…
Jun 26, 2024, 13:47 | Societies
177Lu-DOTATATE as a frontline treatment for somatostatin receptor-positive grade 3 low GEP-NETs
ESMO shared on LinkedIn: "ESMOGI24: Promising data from the phase III NETTER-2 study show that…
Jun 26, 2024, 13:47 | Blog
Petros Grivas: Amazing GU program retreat with stellar colleagues
Petros Grivas shared on X: "Amazing GU program retreat with stellar colleagues, rapid growth to meet…
Jun 26, 2024, 13:38 | Societies
Angela Lamarca: Opening Press Conference at ESMOGI24
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post by…
Jun 26, 2024, 13:34 | Blog
Madeline Pe: Intense 7-day MCCR workshop to help develop research protocols
Madeline Pe, Head of Quality of Life Department at EORTC, shared a post by Matteo…
Jun 26, 2024, 13:33 | Societies
Nieves Martinez Lago: Real-world efficacy and safety of immune checkpoint inhibitors
Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared on X: "Visit…
Jun 26, 2024, 13:29 | OncoDaily Pulse
Introducing the Chair of the Editorial Board of the OncoDaily Medical Journal
Introducing the Chair of the Editorial Board of the OncoDaily Medical Journal We proudly announce…
Jun 26, 2024, 13:27 | Societies
Erman Akkus: Germline mutations are common in non-familial pancreatic cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: "Germline mutations…
Jun 26, 2024, 13:18 | Blog
Stephanie Graff: Changes are to be expected at Brown university
Stephanie Graff shared a post on X: “Thrilled to share that my email, byline, affiliation…
Jun 26, 2024, 13:13 | Blog
Global Myeloma Action Network annual summit - International Myeloma Foundation
International Myeloma Foundation shared a post on X: “At its Global Myeloma Action Network (GMAN)…
Jun 26, 2024, 13:04 | Blog
Shilpa Gupta: Discussing GU Cancers at UroOnco24
Shilpa Gupta shared a post on X: “At Urology Oncology 2024 with a great group of…
Jun 26, 2024, 12:40 | Societies
EGFR co-inhibition in KRAS
Megan Barnet, Medical Oncologist at The Kinghorn Cancer Centre, shared on X: "Great summary from…
Jun 26, 2024, 12:33 | Insight
St. Jude Children’s Research Hospital’s educational event on Pneumocystis Jirovecii in Pediatric Cancer - SIOP
SIOP shared a post on LinkedIn: “Join St. Jude Children’s Research Hospital for their educational…
Jun 26, 2024, 12:21 | Blog
Karen Knudsen: Kicking off our American Cancer Society Cancer Action Network advocacy event
Karen Knudsen shared on X: "What’s a Philadelphia Phillies phan doing at Fenway Park? Kicking off…
Jun 26, 2024, 12:19 | Societies
Brilliant keynote lecture on KRAS inhibitors by Dr. Ryan Corcoran at ESMOGI24
Vittorio Studiale, Medical Oncology resident at AOUP, shared on X: "European Championship of gastrointestinal oncology?…
Jun 26, 2024, 12:09 | Insight
Myeloma Paper of the Day, June 26th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Systematic review of modeling approaches…
Jun 26, 2024, 12:05 | Insight
Piotr Wysocki: Osimertinib after radiochemotherapy improves PFS in EGFR-mutated NSCLC patients – but is it really what they need?
Piotr Wysocki recently posted on LinkedIn: "The results of the LAURA study were presented during a…
Jun 26, 2024, 11:45 | Blog
Sachin Jain: What are your thoughts on how we came to devalue expertise as a society?
Sachin Jain shared on LinkedIn: "A close friend has gotten into my ear about the…
Jun 26, 2024, 11:16 | Blog
Access to medicine is a human right - The Max Foundation
The Max Foundation shared on LinkedIn: "For a decade, Judy struggled seeking medical treatment and…
Jun 26, 2024, 11:01 | Blog
Cancer Research Institute's virtual Patient Immunotherapy Summit
Cancer Research Institute (CRI) shared on LinkedIn: ""I was one of the first lung cancer…
Jun 26, 2024, 10:24 | Blog
Chandler Park: Which patients would you not give EV-Pembro for 1st line metastatic bladder cancer?
Chandler Park shared on X:               . "Which patients would…
Jun 26, 2024, 09:54 | Insight
Miguel Bronchud: How often is post-recurrence treatment reported in adjuvant and neoadjuvant oncology randomized clinical trials?
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: "Clinical trials- not “real life”? They…
Jun 26, 2024, 09:38 | Blog
Katia Roque: Two poster presentations about cervical cancer and GTN at ESMOgynae2024
Katia Roque, Clinical Oncologist at INEN, shared on X: "A great ESMOgynae2024! Two poster presentations…
Jun 26, 2024, 08:52 | Blog
Richard Scolyer: Amazing advances in medicine over the past half century
Richard Scolyer shared on X: "Medicine has made many amazing advances over the past half…
Jun 26, 2024, 08:30 | Insight
IMFINZI (durvalumab) showed improved EFS and OS for MIBC in NIAGARA Phase III trial
First immunotherapy regimen before and after surgery to extend survival in bladder cancer Positive high-level results…
Jun 26, 2024, 08:29 | Blog
Deniz Can Guven: Excited to see younger brother grow with the mentorship of Yuksel Urun
Deniz Can Guven, Editorial Board Member of BMC Cancer, shared a post by Enes Erul,…
Jun 26, 2024, 08:17 | Insight
Comprehensive review of colorectal cancer by Cathy Eng et al.
Arndt Vogel shared on X: "Colorectal cancer in The Lancet: comprehensive review locoregional options: SBRT…
Jun 26, 2024, 08:00 | Insight
New Paper Alert! Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial
Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial…
Jun 26, 2024, 07:54 | Insight
Importance of ctDNA turn around
Aparna Parikh shared on X: "More on adjuvant timing. Will be interesting to see surveillance ctDNA…
Jun 26, 2024, 07:40 | Blog
Mikkael A. Sekeres: So proud to count myself as a mentee to the amazing Dr. Stephen D. Nimer
Mikkael A. Sekeres, Chief of the Division of Hematology at Sylvester Comprehensive Cancer Center, shared…
Jun 26, 2024, 07:39 | Insight
Paolo Tarantino discusses ASCO24 Breast Cancer highlights
Sameh AbdelMalak, Director of Oncology at Educational Partnerships at VuMedi, shared on X: "Check out…
Jun 26, 2024, 06:51 | Insight
Samer Al Hadidi on academic moderation
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, made the following post on X:…
Jun 26, 2024, 06:12 | Insight
Consensus Recommendations from IASLC on neoadjuvant and adjuvant treatment for NSCLC
Rami Manochakian shared a post on X: “Hot off the press! Just published in JTO and…
Jun 26, 2024, 06:07 | Insight
Prognostic significance of Pan-Immune-Inflammation value in mBC treated with Trastuzumab Emtansine
Taha Koray Sahin, Medical Oncologist at Hacettepe University Hospitals, shared on X: “I am excited to…
Jun 26, 2024, 05:36 | Blog
Coping styles and psychosocial symptoms after cancer diagnosis by Luigi Zerbinati et al.
International Psycho-Oncology Society’s X page shared an Italian multicenter study by Luigi Zerbinati et al.…
Jun 26, 2024, 05:25 | Blog
Aditya Juloori: Greys Anatomy highlights COSINR trial at UChicago Cancer Center
Drew Moghanaki shared a post by Aditya Juloori, radiation oncologist at UChicago Medicine on X: “Wait. What?…
Jun 26, 2024, 05:17 | Blog
Sarah P. Psutka: Phenomenal session on key topics in Penile Cancer at UROonco24
Sarah P. Psutka, Assistant Professor of Urology at the University of Washington, shared on X:…
Jun 26, 2024, 05:07 | Blog
ECOG-ACRIN Cancer Research Group study EA9171 is enrolling patients for a clinical trial on Chronic Myeloid leukemia
ECOG-ACRIN Cancer Research Group shared a post on X: “Dr. Amer Zeidan of Smilow Cancer…
Jun 26, 2024, 05:00 | Blog
Lachelle Dawn: Fellows can join the Dana Farber’s division of Leukemia
Lachelle Dawn, Hematologist and Scientist at Dana-Farber Cancer Institute, shared on X: “I work with…
Jun 26, 2024, 04:56 | Blog
The 2023 Impact Factor for CA: A Cancer Journal for Clinicians is 503.1
CA: A Cancer Journal for Clinicians shared on X: “The 2023 Impact Factor for CA: A…
Jun 26, 2024, 04:50 | Blog
Addition of CD28 enhance CAR NK function in blood and solid tumors - MD Anderson Cancer Center
MD Anderson Cancer Center shared a post on X: “Research led by Dr. Katy Rezvani…
Jun 26, 2024, 04:45 | Blog
Carolyn Runowicz: I want to serve as a guide for emerging oncology professionals
Conquer Cancer, the ASCO Foundation recently shared a post on X: “When Carolyn Runowicz, MD, FASCO,…
Jun 26, 2024, 04:38 | Insight
Andy Minn: Summary of our paper on combining JAK inhibitors with anti-PD1 for lung cancer
Andy Minn, Professor at University of Pennsylvania School of Medicine, shared a post on X: "Summary…
Jun 26, 2024, 04:31 | Blog
Estela Rodriguez: My two favorite lung cancer experts on one 'unfiltered' ASCO24 podcast
Estela Rodriguez shared a post by Chadi Nabhan, Chief Medical Officer and Head of Strategy…
Jun 26, 2024, 04:16 | Blog
Anne Marie Mercurio: Off to Chicago for AACI's Clinical Research Innovation meeting
Anne Marie Mercurio, Patient Research Advocate, Freelance Consultant, Writer and Speaker, shared a post on…
Jun 26, 2024, 03:57 | Insight
George Laliotis: Peri-operative FOLFIRINOX improved outcomes in patients with pancreatic cancer
George Laliotis, Translational Medicine Lead of GU Oncologist at Natera, shared a post by JAMA…
Jun 26, 2024, 03:52 | Opinion
Alexandros Alexandropoulos: Some thoughts on Multiple Melanoma clinical trials practice and restrictions
Alexandros Alexandropoulos, Hematologist at Laiko General Hospital, shared a post on X: "Some thoughts on Multiple…
Jun 26, 2024, 03:43 | Blog
Roberto Iacovelli: Honour to have TIDE-A commented by Laurence Albiges, Tom Powles and Dr. Wells
Roberto Iacovelli shared a post on X: "Great honor to have TIDE-A commented by Laurence…
Jun 26, 2024, 03:41 | Insight
Paolo Tarantino: Opportunities to improve outcomes for early recurrent TNBC
Paolo Tarantino shared a post on X:         .  "Early recurrent TNBC (Triple-Negative…
Jun 26, 2024, 03:31 | Insight
Cathy Eng: Creating an international perspective on Colorectal Cancer
Cathy Eng posted on X: "Thanks to co-authors Drs. Takayuki Yoshino, Erika Ruíz-García, Nermeen Mostafa,…
Jun 26, 2024, 03:18 | Insight
Paolo Tarantino: The 5 S rules help memorizing a simple framework to manage ILD
Paolo Tarantino shared on LinkedIn: “T-DXd is rapidly expanding in indications, from HER2+, to HER2-low, and…
Jun 26, 2024, 02:32 | Insight
Eric K. Singhi: Day 2 of Best of ASCO24 Albuquerque
Eric K. Singhi shared a post on X: “Day 2 of Best of ASCO24 Albuquerque kicks…
Jun 26, 2024, 02:26 | Insight
Another important developmental study coming out of SWOG
Benjamin Toll, Associate Director of Education at MUSC Hollings Cancer Center, shared on X: "Another…
Jun 26, 2024, 02:20 | Insight
Brigatinib in NF2-Related Schwannomatosis
Vivek Subbiah shared on X: “Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors. NF2-related schwannomatosis (NF2-SWN,…
Jun 26, 2024, 02:10 | Insight
Intratumoral immune triads are required for effective immunotherapy
NCI Division of Cancer Biology shared on X: "Using preclinical models in an NCI-funded study,…
Jun 26, 2024, 01:56 | Insight
Activity of macrophages in tumors remain poorly defined
Patrick Hwu shared on X: "The metabolic networks regulating the activity of macrophages in tumors…
Jun 26, 2024, 01:34 | Societies
Haggai Elisha: Young minds take on Non-Communicable Diseases
Haggai Elisha, Provost at The Slum and Rural Health Initiative Network (SRHIN), shared on LinkedIn: …
Jun 26, 2024, 01:07 | Blog
Patela Care Foundation was honoured to be invited to the commemoration ceremony of World Refugee Day
Patela Care Foundation shared on LinkedIn:            . "Patela Care Foundation…
Jun 26, 2024, 00:54 | Blog
A video invitation from MASCC President-Elect Professor Florian Scotté for the MASCC/AFSOS/ISOO Annual Meeting
The Multinational Association of Supportive Care in Cancer (MASCC) shared a post on LinkedIn:   …
Jun 26, 2024, 00:28 | Blog
David Zaas: Insightful conversation about the mission of NCI-designated Atrium Health Wake Forest Baptist Comprehensive Cancer Center
David Zaas, President of Atrium Health Wake Forest Baptist, shared a post on LinkedIn:   …
Jun 25, 2024, 21:25 | Blog
Parexel's patient advocacy group
Parexel shared a post on LinkedIn: Parexel recently hosted its inaugural Patient Advocacy Group Forum, focusing…
Jun 25, 2024, 21:06 | Blog
Narjust Florez: My father sharing his experience and the benefits of proper cancer staging in the DR
Narjust Florez shared a post by Teofilo Perez, President of The Dr. Herrera Khoury Clinical…
Jun 25, 2024, 16:24 | Blog
Christy Brown: Thankful for the chance to raise awareness and funds for childhood cancer research
Ryan Green, Director of Cranial and Spinal Technologies Field Education at MedTonic, shared a post by Christy…
Jun 25, 2024, 16:23 | Blog
SIOP has reached 3000 members
SIOP shared a post on LinkedIn: “We have reached 3000 members! To celebrate, we are…
Jun 25, 2024, 16:15 | Career
Emrullah Yilmaz: Excited to join the amivantamab clinical team at Johnson and Johnson Innovative Medicine
Emrullah Yilmaz, Medical Director at Johnson & Johnson Innovative Medicine, shared on LinkedIn: "I’m happy…
Jun 25, 2024, 16:07 | Blog
Join IACH for the upcoming IACH Post EHA and ASCO webinar
The International Academy for Clinical Hematology shared on X/Twitter: "Join us for the upcoming IACH…
Jun 25, 2024, 16:01 | Insight
Paolo Tarantino: Phase 1 trial of the HER2 topo1 ADC SHR-A1811 out in Journal of Clinical Oncology
Paolo Tarantino shared on X:  . "Phase 1 trial of the HER2 topo1 ADC SHR-A1811…
Jun 25, 2024, 15:51 | Career
Agenus Regulatory is hiring Director of Regulatory Affairs
Eric J. Olson, Global Head of Regulatory at Agenus, shared on LinkedIn: "Agenus Regulatory is…
Jun 25, 2024, 15:42 | Blog
Patrick Hwu: Rick Scott and Gus Bilirakis have both been unwavering supporters of Moffitt Cancer Center
Patrick Hwu shared a post LinkedIn: “Senator Rick Scott and Representative Gus Bilirakis have both…
Jun 25, 2024, 15:37 | Insight
New advancements in targeted therapies for lung cancer care - EGFR Positive UK
EGFR Positive UK shared on X: “New advancements in targeted therapies are transforming Lung Cancer…
Jun 25, 2024, 15:31 | Insight
Naveen Pemmaraju: Wei Ying Jen, brilliant hematologist and leukemia doctor
Naveen Pemmaraju shared a post on X: “Shout out to Wei Ying Jen brilliant hematologist…
Jun 25, 2024, 15:29 | Insight
Myeloma Paper of the Day, June 25th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Study of SEER and CDC…
Jun 25, 2024, 15:24 | Insight
Percy Lee: Summary of my presentation, Radiation Is ‘Practice-Changing’ for Some Lung Cancer Subsets
Percy Lee shared a post on X: “Nice summary of my presentation from last week…
Jun 25, 2024, 15:13 | Insight
Anna Avagyan: The Armenian delegation at SIOP Asia 2024
Anna Avagyan, Pediatric Hematologist/Oncologist at the Pediatric Cancer and Blood Disorders Center of Armenia, shared…
Jun 25, 2024, 14:59 | Societies
Sarah Louden: The 2024 summer ASCO Direct review tour officially kicked off
Sarah Louden, Founder and CEO of Total Health, shared on LinkedIn: "The 2024 summer ASCO…
Jun 25, 2024, 14:38 | Insight
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results       …
All: 15762 Posts: 3001 - 3100